PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 54 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $960,000 | +2.1% | 1,579,723 | +9.9% | 0.00% | – |
| Q1 2017 | $940,000 | +179.8% | 1,437,491 | +31.6% | 0.00% | – |
| Q4 2016 | $336,000 | -28.2% | 1,092,680 | +0.2% | 0.00% | – |
| Q3 2016 | $468,000 | +18.2% | 1,090,628 | +0.0% | 0.00% | – |
| Q2 2016 | $396,000 | -32.4% | 1,090,115 | -21.8% | 0.00% | – |
| Q1 2016 | $586,000 | -58.7% | 1,394,436 | +14.9% | 0.00% | -100.0% |
| Q4 2015 | $1,420,000 | +18.5% | 1,214,087 | +3.3% | 0.00% | 0.0% |
| Q3 2015 | $1,198,000 | -16.6% | 1,174,835 | +7.1% | 0.00% | 0.0% |
| Q2 2015 | $1,436,000 | +1.8% | 1,096,871 | +5.0% | 0.00% | 0.0% |
| Q1 2015 | $1,410,000 | +1.6% | 1,044,479 | +4.6% | 0.00% | 0.0% |
| Q4 2014 | $1,388,000 | +3.9% | 998,886 | +1.6% | 0.00% | 0.0% |
| Q3 2014 | $1,336,000 | -27.6% | 982,709 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $1,845,000 | +20.0% | 981,683 | +21.3% | 0.00% | 0.0% |
| Q1 2014 | $1,538,000 | +84.4% | 809,484 | +34.9% | 0.00% | 0.0% |
| Q4 2013 | $834,000 | +0.8% | 600,202 | +2.3% | 0.00% | 0.0% |
| Q3 2013 | $827,000 | +29.2% | 586,525 | +18.2% | 0.00% | 0.0% |
| Q2 2013 | $640,000 | – | 496,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|